Glycoantigen measurement refers to the concentration of glycoantigens in the blood, which serves as an aid in the diagnosis of disease and evaluation of the effectiveness of treatment.
Normal cells can secrete a small amount of glycoantigens, but when certain diseases occur, abnormally proliferating cells will secrete more glycoantigens, thus increasing the glycoantigens in the blood, and tumor cells are the most common abnormally proliferating cells.
Glycoantigen measurement can assist clinical diagnosis, for example, breast cancer often shows elevated Glycoantigen 153, ovarian cancer elevated Glycoantigen 125, and digestive system tumor elevated Glycoantigen 199.
By detecting the change trend of Glycoantigen, it can also evaluate the effect of treatment, and if it continues to decrease, it suggests that the treatment is effective, and should continue to adhere to the treatment.